|
|
||||||||
Ann Thorac Surg 2003;76:821-827
© 2003 The Society of Thoracic Surgeons
a Heart Institute (Incor), São Paulo University Medical School, São Paulo, Brazil
Accepted for publication March 13, 2003.
* Address reprint requests to Dr Moreira, Heart Institute (Incor), University of São Paulo Medical School, Av. Dr. Enéas Carvalho Aguiar, 44-2° Level, Block 2, Room 13, São Paulo SP, Brazil 05403-000
e-mail: dcimoreira{at}incor.usp.br
BACKGROUND: Palliative procedures have been proposed for treatment of dilated cardiomyopathies. This study analyzes long-term outcomes of 43 patients who underwent dynamic cardiomyoplasty.
METHODS: Patients were in New York Heart Association class III (n = 35) or IV (n = 8) before the procedure. Hospital mortality was 2.2%, and patients were followed for 44 ± 33 months. Thirty-nine patients completed the skeletal muscle adaptation period, and the muscle flaps were stimulated to contract in concert with every cardiac beat (n = 27) or with every other beat (n = 12).
RESULTS: One-year event-free survival was 81.3% ± 5.9%; 2-year, 65.1% ± 7.2%; 5-year, 34.7% ± 7.2%; and 9-year, 10.8% ± 5.3%. Causes of late deaths were equally divided between progressive heart failure and arrhythmia-related events. Multivariable Cox proportional hazard regression identified that functional class IV, high pulmonary vascular resistance, and muscle flap stimulation synchronized to every cardiac beat were independent predictors of poor event-free survival. The same factors were associated with the occurrence of progressive heart failure, but none was a predictor of arrhythmia-related deaths. Five-year survival of patients maintained with the muscle flap stimulated at every other cardiac beat was 58.3% ± 14.2%. Skeletal muscle stimulation protocols also influenced the long-term behavior of left ventricular ejection fraction.
CONCLUSIONS: Long-term results of dynamic cardiomyoplasty are limited by the patients preoperative condition and by a high incidence of sudden cardiac death. These results may be improved using modified skeletal muscle stimulation protocols and cardioverter-defibrillator implantation, while maintaining dynamic cardiomyoplasty as an option for selected patients.
This article has been cited by other articles:
![]() |
J. C. Chachques Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure? Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 201 - 203. [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, O. J. Jegaden, V. Bors, T. Mesana, C. Latremouille, P. A. Grandjean, J. N. Fabiani, and A. Carpentier Heart transplantation following cardiomyoplasty: a biological bridge Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 685 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text] |
||||
![]() |
J. C Chachques, C. Salanson-Lajos, P. Lajos, A. Shafy, A. Alshamry, and A. Carpentier Cellular Cardiomyoplasty for Myocardial Regeneration Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |